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Diabetes is affecting the social and economic developments in developing countries
like Sri Lanka. Siddha Medicine (Tamil Medicine) is mostly practiced in the Eastern and
Northern Provinces of Sri Lanka. Our recent review of Sri Lankan Siddha historical
documents identified 171 plant species used to prepare anti-diabetic preparations.
On the other hand, there is no study of plants currently used to treat diabetes in
Sri Lankan Siddha Medicine. Hence, the aim of this study is to identify and document
the plant species currently used in anti-diabetic preparations in Eastern Province, also
enabling a comparative analysis with historical uses. Further, assessing the level of
scientific evidence (in vitro, in vivo, and clinical studies) available for recorded species. A
systematically prepared questionnaire was used to conduct an ethnobotanical survey
with 27 Siddha healers residing in Eastern Province to identify the currently used
anti-diabetic plants. Furthermore, Web of Science electronic database was used to
assess the level of scientific evidence available excluding widespread and very well
studied species. On average 325 diabetic patients were seen by 27 healers per week.
Interestingly, inorganic substances, and animal parts used as ingredients in historical
anti-diabetic preparations are currently not used in Eastern Province. A total of 88
plant species from 46 families were reported in this study. Syzygium cumini (L.) Skeels
was the most frequently recorded species and the largest number of taxa are from
Fabaceae. Remarkably, one third of reported species were not stated in Sri Lankan
Siddha historical documents. The highest number of plant species (59%) have been
studied up to an in vivo level followed by no scientific evidence for anti-diabetic activity
found (27%), clinical evidence (10%), and in vitro (2%). This is the first ethnobotanical
study of plants used to treat diabetes by Siddha healers in the Eastern Province in Sri
Lanka. Moreover, awareness should be created to the diabetics about the side effects
of herb-drug interactions and complications caused by taking both herbal preparations
and biomedical drugs.
Keywords: Sri Lanka, diabetes mellitus, Tamil medicine, Syzygium cumini, Fabaceae, Eastern Province,
ethnobotany, Siddha Medicine
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INTRODUCTION
There are an estimated 1.16 million people (20–79 years old)
with diabetes in Sri Lanka with 0.60 million undiagnosed cases.
Furthermore, in 2015 16,319 (20–79 years old) deaths caused
by diabetes were recorded (IDF, 2015). About 70% of rural
population relies on traditional medicinal system as their primary
health care (Perera, 2012). While there are two types of diabetes:
Type 1 (insulin deficiency) and type 2 (insulin resistance),
globally the majority of cases are type 2 diabetes. Heart attacks,
lower limb amputation, blindness, and kidney failure are mostly
caused by diabetes. The number of diabetics is rising fast in
middle- and low-income countries (WHO, 2017).
Sri Lanka is a South Asian island situated in the Indian
Ocean. It has 65,610 km2 area with a population of 21.2 million
(Department of Census and Statistics Sri Lanka, 2017). The
largest (75%) ethnic group is Sinhalese, followed by Sri Lankan
Tamil (11%), Sri Lanka Moor (9%), and Indian Tamil (4%). The
official and national languages of Sri Lanka are Sinhala and Tamil.
The major and official religion is Buddhism (70%) followed by
Saivism (13%), Islam (10%), and Christianity (7%) (Department
of Census and Statistics Sri Lanka, 2012). There are three climatic
zones (dry, intermediate, and wet) in Sri Lanka (Department of
Meteorology Sri Lanka, 2016).
A total of 4,143 plant species of 214 families identified in Sri
Lanka were listed in a work by Senaratna (2001). Furthermore,
75% of these species were indigenous whereas 25% of them
were introduced/exotics, with 32% having become naturalized
and 68% being under cultivation (Senaratna, 2001). In 2010
nearly 29.7% of Sri Lankan land area is covered by natural
forests (Forest Department Sri Lanka, 2017). The vegetation of
Sri Lanka can be categorized as follows according to the impact
of soil and elevation: montane, sub montane, lowland rain,
moist monsoon, dry monsoon, riverine dry, sparse and open,
and mangrove forests (Forest Department Sri Lanka, 2017). The
most frequently identified plant families in the montane forests
were Lauraceae (Actinodaphne, Cinnamomum, and Litsea) and
Myrtaceae (Eugenia, Rhodomyrtus, and Syzygium) (Werner and
Balasubramaniam, 1992). The main Sri Lankan export crops are
Camellia sinensis (tea), Hevea brasiliensis (rubber), and Cocos
nucifera (coconut) (Department of Census and Statistics Sri
Lanka, 2017).
Four traditional medicinal systems (Ayurveda, Siddha, Unani,
and Deshiya Chikitsa) are currently practiced in Sri Lanka
(Weragoda, 1980). Siddha (or Tamil) Medicine is mostly
practiced in the Eastern and Northern Provinces of Sri Lanka
(Sivashanmugarajah, 2000). So far, only two ethnobotanical
surveys have been carried out in Jaffna (Rajamanoharan,
2014) and Vavuniya (Rajamanoharan, 2016), Northern Province.
However, so far, no ethnobotanical survey has been carried out in
Eastern Province. A recent review of Sri Lankan Siddha historical
documents revealed 171 species in 73 families were used to treat
diabetes in Sri Lankan Siddha Medicine (Sathasivampillai et al.,
2017). However, there is no documentation of species currently
used to treat diabetes in Sri Lankan Siddha Medicine.
For centuries a large number of disorders including diabetes
have been managed and treated using traditional herbal
preparations (Nearing, 1985). Ethnobotanical surveys focusing
on the use of medicinal substances play an important role
in safeguarding and understanding local/traditional and local
knowledge and are seen a starting point for drug discovery
(Fabricant and Farnsworth, 2001). Safeguarding is, however,
only one element of such research. Modern use of “traditional”
medicines are embedded in complex expectations both by those
who are the keepers of this knowledge and by the wider society.
However, outcomes of ethnobotanical surveys are not frequently
compared with the available published scientific reports to study
the pharmacological properties of plants used in the preparations.
Recent surveys on anti-diabetic plants have been published for
many countries such as India (Vidyasagar and Siddalinga, 2013),
South Africa (Davids et al., 2016), Nigeria (Salihu Shinkafi et al.,
2015), México (Andrade-Cetto and Heinrich, 2005), Turkey
(Durmus¸kahya and Öztürk, 2013), and China (Guo et al., 2017).
Sri Lankan local and traditional medicine is a practice which
has developed as a part of the historical development of Sri
Lanka incorporating not only autochthonous traditions but also
the multiple impacts of diverse cultures. Our previous research
(Sathasivampillai et al., 2017) identified a large number of
taxa documented in historical texts which were a part of the
formal curriculum for training Siddha medical practitioners for
conditions associated with diabetes.
Therefore, the aim of this work is to identify and document
the species currently used to treat diabetes in Eastern Province,
Sri Lanka in Siddha Medicine, enabling a comparative analysis
with the historical uses. With this we want to contribute to an
understanding of continuity and change of practice as it relates to
diabetes in this culture. This also forms a basis for a systematic,
comparison with medicinal plants usage in other regions of Sri
Lanka. In addition, we assess the levels of scientific evidence (in
vitro, in vivo, and clinical studies) of the reported species based
on a bibliographic assessment.
BACKGROUND AND METHODS
The Study Region
This ethnobotanical study was conducted with Siddha healers
residing in the Eastern Province in the dry climatic zone of Sri
Lanka which consists of three districts (Batticaloa, Ampara, and
Trincomalee) (Figure 1). Tamil is the major language spoken in
this area. Siddha Medicine is mostly practiced in Tamil speaking
regions around the world (AYUSH, 2016).
Ethical Approval of the Research
Research ethical approval was obtained from UCL Research
Ethics Committee (9141/001) on 13.06.2016 prior starting the
investigation in Sri Lanka. The purpose of this study and
informed consent page were read to each healer before beginning
the interview. The interview was carried out only after receiving
the verbal consent from each informant. Healers participated
voluntarily in this study, were free to withdraw at any point in
time and no compensation was provided.
This study was conducted recognizing the relevant obligations
under the Convention on Biological Diversity and subsequent
agreements, most notably the Nagoya Protocol which had at the
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time of writing (07.01.2018) not yet been signed or ratified by Sri
Lanka, while the UK ratified it on 22.02.2016 (https://www.cbd.
int/abs/doc/protocol/nagoya-protocol-en.pdf 07.01.2018). Also,
the right to authorship and use the traditional knowledge of
all informants were preserved. Using this information except
scientific publication requires permission from the traditional
owners of knowledge. However, no permission is required from
the government to collect and preserve plant material samples
within Sri Lanka. It was started prior to the publication of the
ConsEFS statement on best practice in ethnopharmacological
research (Heinrich et al., 2018), but has followed these
guidelines.
Ethnobotanical Data Collection and
Interviews
This ethnobotanical investigation was conducted from July to
September 2016. SVS conducted the interviews jointly with PRR
(community health medical officer at Planning Unit, Eastern
Provincial Department of Indigenous Medicine and in charge of
Eastern Provincial Herbal Garden, Trincomalee) being present
during the interviews.
The interviews were carried out in Tamil. Only Siddha healers
whose families have been practicing Siddha Medicine for at least
two generations and are registered at the Sri Lanka Ministry
of Indigenous Medicine were included in this study. Siddha
FIGURE 1 | Map of study region based on https://en.wikipedia.org.
healers were actively chosen by the community health medical
officer from the database of registered healers. Permission and
appointments were obtained verbally from each healer by the
community healthmedical officer. Then, the interviews were held
at Siddha healers’ homes.
Initially, 33 Siddha healers were approached. However,
6 of them do not practice any treatment for diabetes.
Hence, they were excluded from this study. Interviews using
a questionnaire including semi-structured questions were
conducted with the healers (Appendix). The questions focused
on social and demographic data such as gender, age, and
experience and species currently used to treat diabetes.
With each healer, the interview lasted for a minimum of
15 minutes.
Voucher Specimens and Plant
Identification
Reported species which are available locally or cultivated were
collected. The fieldwork for collecting plant part samples was
conducted during September 2016 to June 2017, a period
ideal for collecting flowering and fruiting specimens. Specimens
are deposited at the Herbarium of the Eastern Provincial
Herbal Garden, Trincomalee (for voucher specimen numbers
see Table 1) and identified by PRR. Siddha healers mentioned
Tamil names of the species. Scientific names and families are
based on Sugathadasa et al. (2008) and validated using The Plant
List (2013) and the Royal Botanic Gardens Kew, Medicinal Plant
Service (2018).
TABLE 1 | Demographic data of the Siddha healers (N = 27).
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Data Analysis
A database of reported species including family, scientific name,
part used, and number of participants citing it as being of
medicinal importance was created. Plant species currently used to
treat diabetes by Siddha healers (this study) were compared with
the species historically used to treat diabetes in Sri Lankan Siddha
Medicine (Sathasivampillai et al., 2017). Also, species confirmed
in this work were compared with the species used to treat diabetes
reported in the ethnobotanical studies previously carried out
in the other areas where Siddha Medicine is mostly practiced
in Jaffna (Rajamanoharan, 2014) and Vavuniya (Rajamanoharan
(2016). Other comparisons with ethnobotanical information
were carried out based on local knowledge of Eastern Province
of Sri Lanka by the authors SVS and PRR. Furthermore, an
assessment of the levels of scientific evidence of each species was
carried out using the electronic database Web of Science until
September 2017. The method described in Sathasivampillai et al.
(2017) was followed to identify the relevant published studies.
Species listed in Brendler (2010), Upton et al. (2016), American
Herbal Pharmacopoeia (2017), European Medicines Agency
(2018), andWHO (1999, 2004, 2007, 2009) were considered to be
very well studied and global plants. Therefore, they were excluded
from the literature search to identify the level of scientific
evidence.
RESULTS AND DISCUSSION
Socio-Demographic Characteristics of the
Siddha Healers Participated in This Study
A total of 27 Siddha healers residing in Eastern Province and
currently treating diabetes were interviewed in detail for this
study. The majority of participants were men. The highest
number of participants were in the 61–70 age group. Also, the
majority of the healers had 41–50 years of experience practicing
Siddha Medicine (Table 1).
Current Diagnosis Methods Employed by
Siddha Healers
This study relies on the self-reporting by the healers on their
practice. While some of the cases of diabetes treated may well
be confirmed using bio-medical diagnosis, it was not possible in
the context of this study to ascertain any diagnosis. Diabetes is
termed as Neerilivu ( ) in Siddha Medicine (Anonymous,
2000). The common symptoms of diabetes in Siddha Medicine
mentioned include dry tongue, chest and throat; feeling lazy, ants
and flies gather around the urine, weight loss, feeling thirsty,
and excessive urination (Anonymous, 2000, 2003). Diabetes is
categorized into 24 types referring to the color and taste of
the urine in Siddha Medicine (Sithamparthanuppillai, 1982). In
Siddha Medicine eight diagnostic methods (pulse examination,
touch, tongue examination, body color, speech, eye, stool, and
urine) are used to diagnose a disorder (Narayanaswami, 1975).
However, in this investigation Siddha healers mentioned they
only use pulse reading to diagnose diabetic cases combination
with above mentioned Siddha symptoms of diabetes.
Number of Diabetic Patients Seen by a
Siddha Healer
According to the information provided by the Siddha healers,
on average 12 diabetics are seen by a healer per week. However,
they did not show any written evidences of number of patients
consulting them. Also, they did not have any information of
how many of the patients come back for a regular consultation.
Usually preparations sufficient for 1 month was given to each
patient. Anti-diabetic preparations are prepared by the healers at
home.
Types of Ingredients Currently Used
Herbal, inorganic (such as metals and minerals), and
animal products have been recorded commonly as
elements of Siddha Medicine (NIS, 2018). Also, these
three types of ingredients were included in Siddha
historical documents analyzed for anti-diabetic preparations
(Sathasivampillai et al., 2017). Siddha healers in this study
reported only botanical ingredients to prepare anti-diabetic
preparations.
Species Reported by Siddha Healers
Overall, 88 species from 46 families was documented in this
study (Table 2). Syzygium cumini was the most cited species
(cited by 21 Siddha healers) followed by Gymnema sylvestre,
Artocarpus heterophyllus, Salacia reticulata, and Achyranthes
aspera. The largest number of reported taxa are from the
Fabaceae. Leaves were cited as the most frequently used plant
part followed by fruits, whole plant, root, and bark. The
majority of the plants documented in this study were South
Asian medicinal plants, like Withania somnifera, Typhonium
trilobatum, Tribulus terrestris, Toddalia asiatica, and Tinospora
sinensis followed by food plants including Achyranthes aspera,
Borassus flabellifer, Cinnamomum verum, Eleusine coracana, and
Limonia acidissima.
Remarkably, one third of the species reported in this study had
not been recorded before either in anti-diabetic preparations of
Sri Lankan Siddha historical documents or in the ethnobotanical
surveys carried out in regions of Sri Lanka where Siddha
Medicine is practiced (marked as “#” in Table 2). For example,
Sesbania grandiflora and Pedalium murex are reported for the
first time in this study as ingredients in Siddha anti-diabetic
preparations in Sri Lanka. At the same time there is a strong
overlap with the historical Siddha documents with 61% of
the recorded species also stated as anti-diabetic preparations
including Ficus racemosa and Salacia reticulata. Since these are
used as textbooks for training Siddha healers this indicates
that both written records (Leonti, 2011) and oral transmission
/ local innovations form the basis for the species used. The
most frequently used species in this study (S. cumini) was
also used in the anti-diabetic preparations in the historical
documents. Senna auriculata is the most frequently stated in
the historical preparations used to treat diabetes in Sri Lankan
Siddha Medicine (Sathasivampillai et al., 2017) but only five
healers in this work consider it to be a useful anti-diabetic
therapy.
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TABLE 2 | Reported plant species used to treat diabetes in Siddha Medicine in Eastern Province (n = 27).
Family, scientific name, voucher specimen
identification
Tamil name Part used Local use, number of times cited
Food Medicine Other
ACANTHACEAE
Hygrophila auriculata (Schumach.) Heine
(Neermulli)
Leaf 4




Achyranthes aspera L. (VS001)
(Naayuruvi)
Whole plant 11
Aerva lanata (L.) Juss. (VS003)#
(Thengaaippookkeerai)
Whole plant 2































Catharanthus roseus (L.) G.Don (VS013)*#
(Patti)
Root 1
















Calotropis procera (Aiton) Dryand.#
(Vellerukku)
Root 1
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TABLE 2 | Continued
Family, scientific name, voucher specimen
identification
Tamil name Part used Local use, number of times cited
Food Medicine Other
ASTERACEAE
Cyanthillium cinereum (L.) H.Rob. (VS016)
(Seetheviyaar sengkaluneer)
Whole plant 2




























Terminalia arjuna (Roxb. ex DC.) Wight & Arn. (VS041)*
(Maruthu)
Bark 1







Evolvulus nummularius (L.) L. (VS020)#$
(Vellai vittunukiraanthi)
Whole plant 1
Ipomoea aquatica Forssk. (VS025)
(Vallal)
Leaf 4








Coccinia grandis (L.) Voigt (VS015)
(Kovvai)
Leaf 9
Momordica charantia L. (VS027)*
(Paahal)
Fruit, leaf 3
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TABLE 2 | Continued
Family, scientific name, voucher specimen
identification
Tamil name Part used Local use, number of times cited
Food Medicine Other
FABACEAE









Pongamia pinnata (L.) Pierre (VS035)#$
(Pungu)
Root 3





Senna sophera (L.) Roxb. (VS038)
(Ponnaavarai)
Flower 2
Sesbania grandiflora (L.) Pers. (VS039)#
(Ahaththi)
Leaf 3












Abutilon indicum (L.) Sweet
(Thuththi)
Whole plant 3




Azadirachta indica A.Juss. (VS008)*
(Vembu)
Bark, tender, leaf 4
MENISPERMACEAE
Coscinium fenestratum (Goetgh.) Colebr.
(Maramanjal)
Stem 4




Artocarpus heterophyllus Lam. (VS007)
(Palaa)
Mature 13
Ficus benghalensis L. (VS021)
(Aal)
Bark 2
Ficus racemosa L. (VS022)
(Aththi)
Bark 2
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TABLE 2 | Continued
Family, scientific name, voucher specimen
identification
Tamil name Part used Local use, number of times cited
Food Medicine Other
MYRTACEAE
Syzygium aromaticum (L.) Merr. & L.M.Perry*
(Karaambu)
Flower, bud 4
Syzygium cumini (L.) Skeels (VS040)
(Naaval)




































Chrysopogon zizanioides (L.) Roberty
(Ilaamichchai)
Root 1
Cynodon dactylon (L.) Pers. (VS017)*#
(Aruhu)
Whole plant 3
Eleusine coracana (L.) Gaertn.
(Kurakkan)
Seed 1
Oryza sativa L. (VS031)*
(Nel)
Seed 4
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TABLE 2 | Continued
Family, scientific name, voucher specimen
identification
Tamil name Part used Local use, number of times cited
Food Medicine Other
RUTACEAE
Aegle marmelos (L.) Corrêa (VS002)*
(Vilvai)
Bark, fruit 7
Limonia acidissima Groff (VS026)$
(Vilaaththi)
Fruit 2
Murraya koenigii (L.) Spreng. (VS029)*
(Karivembu)
Leaf 10





























Tribulus terrestris L. (VS044)*
(Nerunjchil)
Whole plant 1
Local use, Food, medicinal, and other uses of plant species were categorized according to the most common local use of the particular plant species. *Plant species excluded from
further analysis in this study. #Plant species had not been reported in either anti-diabetic preparations in Sri Lankan Siddha historical documents or ethnobotanical surveys carried out
in Siddha Medicine practicing regions in Sri Lanka. $Plant species without any bioscientific evidence for anti-diabetic activity.
A total of eight species were recorded previously to treat
diabetes in Northern Province. Seven species were reported
in Vavuniya and only Scoparia dulcis was recorded in Jaffna
(Rajamanoharan, 2014). Species such as Momordica charantia
and G. sylvestre were reported in both Eastern and Northern
Provinces. Also, species such as Andrographis paniculata and
Toddalia asiatica had been only confirmed in Eastern Province.
Interestingly, the most frequently mentioned species (S. cumini)
in this study and cited in historical documents (S. auriculata) had
not been recorded in Northern Province (Rajamanoharan, 2014,
2016; Sathasivampillai et al., 2017).
Side effects and toxicity studies of plant extracts and herbal
preparations play a very important role in assessing the safety
and efficacy of drugs purposes. Some species are clearly toxic,
like Aristolochia bracteolata (cf. Michl et al., 2016) and their
use cannot be endorsed. More complex is the situation with
regards to potential herb-drug interactions. However, a detailed
analysis of such interactions would be limited by the evidence
for specific interactions, for example, with the multiple steps of
the detoxification system of xenobiotics that could be affected
and the specific composition of the preparation which might
be active. This therefore, should be the focus of specific
studies of the most important plants using well-characterized
extracts.
Levels of Scientific Evidence of Reported
Species
Based on the Web of Science electronic database of the
pharmacological evidence linked to anti-diabetic activities of the
species were assessed [excluding 39 (44%) very well studied and
globally distributed species, marked with an “∗” in Table 2].
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The levels of scientific evidence were established, including
information on the plant part used, active extract or compound,
model, dose, and duration for the remaining 49 (56%) species
(Appendix). Four levels of scientific evidence were established:
1. There is no reported bioscientific evidence
2. In vitro evidence only
3. In vivo evidence and active compound identified and
4. Clinical evidence and active compound identified.
Species With No Bioscientific Evidence
There was no scientific evidence for anti-diabetic activity
found for 13 species (27%). Hence, Anti-diabetic and toxicity
studies should be carried out in the future focusing on the
most frequently used species such as Limonia acidissima,
Crateva adansonii, Evolvulus nummularius, P. murex, and
Mesua ferrea.
In vitro Evidence Reported
Only for Mukia maderaspatana and Setaria italica in vitro
bioassays form the basis for as an evidence base. Ethanol
extract of S. italica seeds showed inhibitory activity in the
α-glucosidase inhibition assay with an IC50 1.1 to 1.4µg/ml
(Kim et al., 2011). The active compounds have so far not
been isolated from either of these species calling for further
phytochemical studies, especially for S. italica (foxtail millet)
seeds since these had higher α-glucosidase inhibitory activity at
a low dose (IC50 1.1 to 1.4µg/ml). This species would also be of
particular interest because of its wide distribution and use as a
(specialist) food.
In vivo Evidence and Active Compound Found
The majority (29 out of 49, 59%) have in vivo evidence
including Coccinia grandis, Sesbania grandiflora, Cardiospermum
halicacabum, Thespesia populnea, and Coscinium fenestratum.
Compounds with anti-diabetic activity have been isolated
from eight species (Eclipta prostrata, Cheilocostus speciosus,
S. auriculata, F. benghalensis, Myristica fragrans, S. cumini,
Averrhoa carambola, and S. dulcis) studied in in vivo models.
Costunolide (5 mg/kg) isolated from C. speciosus roots was
orally administered to Streptozotocin induced diabetic rats daily
for 30 days. This treatment significantly reduced blood glucose
concentration (Eliza et al., 2009b). In another study 2-(3-acetoxy-
4,4,14-trimethylandrost- 8-en-17-yl) (5 mg/kg) identified in
S. auriculata flowers orally administered to Alloxan induced
diabetic rats for 15 days decreased elevated blood glucose levels
(Venkatachalam et al., 2013). Further phytochemical, in vivo,
clinical, and toxicity studies should be carried out to identify the
active compounds and further evaluate the anti-diabetic activities
of the species with reported in vivo evidence. Species such
as Borassus flabellifer, Alternanthera sessilis, Ipomoea aquatica,
Senna sophera, and Chrysopogon zizanioides are potential
candidates for clinical studies.
Clinical Evidence and Active Compound Found
Clinical evidence is available for 5 out of 49 species (10%):
Cyanthillium cinereum, S. reticulata, Artocarpus heterophyllus,
Eleusine coracana, and F. racemosa. So far anti-diabetic
compounds have only been isolated from F. racemosa, but
these compounds have not been studied in clinical trials. F.
racemosa bark water extract (1.2 g/d) orally administered to type
2 diabetic patients (18 men and 12 women) for 1 month showed
15% of reduction of fasting blood glucose levels and 22% of
reduction of postprandial blood glucose levels (Ahmed et al.,
2011). However, the authors did not state whether this clinical
trial was a controlled trail or not. In another study F. racemosa
bark extract (100mg twice a day) was administered orally to
diabetics (25 male and 25 female) for 15 days and reduced serum
glucose concentrations (Gul-e-Rana et al., 2013).
CONCLUSION
This is the first ethnobotanical study of plants used to treat
diabetes by Siddha healers in the Eastern Province in Sri
Lanka. This study aimed at documenting and comparing the
current ethnobotanical knowledge from the Siddha healers linked
to the treatment of diabetes with plant species recorded in
the historical documents and in the few other studies which
exist on Siddha medicine. Overall, the bioscientific evidence is
limited and priority should be given to the most widely used
species. While we excluded globally distributed species, some
of them have a better evidence base in terms of safety and
pharmacology / clinical effectiveness, and thus they may be
better suited in primary health care projects. With this medical
tradition’s importance also as an element of primary health care,
scientific evidence is needed first and foremost on the Siddha
medicines’ safety and lack of toxicity [e.g., Aristolochia species
like A. bracteolate clearly not be endorsed as a phytomedicine
(Michl et al., 2016)]. This study demonstrates that there is a
wealth of knowledge among Siddha healers about managing
diabetes, and that there is an urgent need for more studies
providing a better evidence-base for these uses. In many cases
the chemistry of the species is known relatively well and thus
further bibliographic assessments can form a starting point for
such an assessment. In further steps observational and ideally
intervention studies are essential.
Ethnobotanical surveys should be carried out in the other
regions of Sri Lanka for documenting the useful species utilized
by Siddha healers before this knowledge may disappear in
the future. Importantly, as many diabetics are currently taking
combination of herbal preparations with biomedical medications
such as Metformin, ethnobotanical surveys should be carried
out with diabetics to create awareness of potential herb-drug
interactions, side effects and complications caused by taking both
biomedical and traditional medicinal preparations.
Furthermore, the Sri Lankan government also needs to advice
traditional healers, biomedical doctors, and the public on the
species safety and potential uses. Also, potential interactions
between “Western” and traditional medicinal preparations need
to be assessed and then should communicated to a wider
public. Last but not least, this work provides new opportunities
to discover novel compounds which could be used as active
compounds in future drug discovery.
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